KG

Kls Martin Group

www.klsmartin.com link_icon

Company Research Report: KLS Martin Group





Company Overview



  • Name: KLS Martin Group

  • Mission: Surgical Innovation is our Passion

  • Founded: 1896, in Mühlheim an der Donau, Germany

  • Founders: No specific information found

  • Key People:

  • Christian Leibinger: Managing Director

  • Headquarters: Tuttlingen, Germany

  • Number of Employees: No information is available

  • Revenue: Over 430 million Euro in 2023

  • Known For: Globally leading supplier of medical technology solutions for various surgical fields including implant systems, electrosurgery units, surgical lasers, OR lights, and surgical instruments.


Products



1. maXium® smart C
  • Description: High-frequency electrosurgery device.

  • Key Features: Designed for diverse surgical requirements with high performance and safety standards.


2. marPOR® Implants
  • Description: Implants made from UHMWPE, offering lightweight and natural tactile properties.

  • Key Features:

  • Manufactured in a cleanroom environment.

  • Sterilized and packaged employing an ETO process in double blister packaging.

  • Enhanced porosity structure promoting vascularization and bone growth.

  • Compatible with maxDrive® screws for fixation.


3. IPS® (Individual Patient Solutions)
  • Description: Holistic solutions for planning and simulating surgical interventions customized to each patient's needs.

  • Key Features:

  • Software tools like IPS CaseDesigner® aid in the planning and simulation of surgeries.

  • Production of custom implants and anatomical models using advanced manufacturing technologies.


4. SonicWeld Rx® System
  • Description: Features resorbable polymers combined with ultrasonic technology for maxillofacial applications.

  • Key Features:

  • Allows the fixation of SonicPins by leveraging ultrasonic vibrations.

  • Eliminates the need for a second surgery for implant removal.


5. Diodengepumpter Nd:YAG-Laser Limax®
  • Description: Laser system for surgical applications.

  • Key Features: Specific wavelength enables efficient tissue cutting and coagulation.


Recent Developments



  • New Facility in the USA (2024):

  • Description: Completion of a state-of-the-art facility in Jacksonville, Florida for the planning and manufacturing of customized implants.

  • Significance: Reflects major investment (~38 million USD) for expansion in the American market.


  • New Site in Fridingen (2024):

  • Description: Opening of a modern instrument production plant at the site of the former Lawton GmbH & Co. KG.

  • Significance: Increases production capacity, facilitates collaboration between production and development, and highlights the rapid 10-day relocation endeavor.


  • Expansion in Workforce:

  • Implication: The expansion of facilities in Jacksonville and Fridingen indicates growth in production capacity leading to the creation of new jobs.


Please note that some specific details about founding individuals and total employee count were not available based on the provided data.